![Didier Reymond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Didier Reymond worked as an Associate Director of Scientific Affairs at Merck Frosst Canada Ltd. He then worked as the Executive Vice President of Clinical Development at Thallion Pharmaceuticals, Inc. from 2007 to 2013.
Dr. Reymond received an undergraduate degree from the University of Lausanne.
Eerdere bekende functies van Didier Reymond
| Bedrijven | Functie | Einde |
|---|---|---|
| THALLION PHARMACEUTICALS INC. | Hoofd Techniek/Wetenschap/O&O | 30-04-2013 |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Corporate Officer/Principal | - |
Opleiding van Didier Reymond
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thallion Pharmaceuticals, Inc.
 Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new pharmaceutical products | Health Technology |
Merck Frosst Canada Ltd.
Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
